From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

Dianne Bosch, Kim J M van der Velden, Aart Beeker, Hendrik P van den Berg, André M Bergman, Maarten J van der Doelen, Alfons J M van den Eertwegh, Mathijs P Hendriks, Thomas M A Kerkhofs, Addy C M van de Luijtgaarden, Niven Mehra, Reindert J A van Moorselaar, Metin Tascilar, Walter L Vervenne, Nir I · 2026

Read From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer by Dianne Bosch, Kim J M van der Velden, Aart Beeker, Hendrik P van den Berg, André M Bergman, Maarten J van der Doelen, Alfons J M van den Eertwegh, Mathijs P Hendriks, Thomas M A Kerkhofs, Addy C M van de Luijtgaarden, Niven Mehra, Reindert J A van Moorselaar, Metin Tascilar, Walter L Vervenne, Nir I (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13287194.txt.

Description

Dianne Bosch and co-authors give a 2026 real-world study of prostate cancer care in the Netherlands. The focus is metastatic castration-resistant prostate cancer with BRCA mutations. Olaparib was the first PARP inhibitor approved for this group, yet trial patients are often fitter than clinic patients.

Data came from ten hospitals in a Dutch registry for men diagnosed over several years. The study tracks who got genomic testing, who then got olaparib alone, and how they fared. That chain from test to treatment is the core of the paper. Readers can see where real care matches trial hopes and where patients fall away before treatment starts.

Catalog record

CREATORDianne Bosch, Kim J M van der Velden, Aart Beeker, Hendrik P van den Berg, André M Bergman, Maarten J van der Doelen, Alfons J M van den Eertwegh, Mathijs P Hendriks, Thomas M A Kerkhofs, Addy C M van de Luijtgaarden, Niven Mehra, Reindert J A van Moorselaar, Metin Tascilar, Walter L Vervenne, Nir I
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE30 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13287194

Browse the full library · About the Tower of Babel